References
- Baldwin RM, Jewell WT, Fanucchi MV, et al. (2004). Comparison of pulmonary/nasal CYP2F expression levels in rodents and rhesus macaque. J Pharmacol Exp Ther 309:127–36
- Baldwin RM, Shultz MA, Buckpitt AR. (2005). Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J Pharmacol Exp Ther 312:857–65
- Bieche I, Narjoz C, Asselah T, et al. (2007). Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731–42
- Chen N, Whitehead SE, Caillat AW, et al. (2002). Identification and cross-species comparisons of CYP2F subfamily genes in mammals. Mutat Res 499:155–61
- Lanza DL, Code E, Crespi CL, et al. (1999). Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 27:798–803
- Nakajima T, Elovaara E, Gonzalez FJ, et al. (1994). Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem Res Toxicol 7:891–6
- Nhamburo PT, Kimura S, McBride OW, et al. (1990). The human CYP2F gene subfamily: identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping. Biochemistry 29:5491–9
- Nishimura M, Yaguti H, Yoshitsugu H, et al. (2003). Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 123:369–75
- Renaud HJ, Cui JY, Khan M, Klaassen CD. (2011). Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice. Toxicol Sci 124:261–77
- Ritter JK, Owens IS, Negishi M, et al. (1991). Mouse pulmonary cytochrome P-450 naphthalene hydroxylase: cDNA cloning, sequence, and expression in Saccharomyces cerevisiae. Biochemistry 30:11430–7
- Sasaki E. (2015). Prospects for genetically modified non-human primate models, including the common marmoset. Neurosci Res 93:110–5
- Sheets PL, Yost GS, Carlson GP. (2004). Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1. J Biochem Mol Toxicol 18:92–9
- Shimada T, Takenaka S, Kakimoto K, et al. (2016). Structure-function studies of naphthalene, phenanthrene, biphenyl, and their derivatives in interaction with and oxidation by cytochromes P450 2A13 and 2A6. Chem Res Toxicol 29:1029–40
- Shimizu M, Iwano S, Uno Y, et al. (2014). Qualitative de novo analysis of full length cDNA and quantitative analysis of gene expression for common marmoset (Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencing. PLoS One 9:e100936
- 't Hart BA, Abbott DH, Nakamura K, Fuchs E. (2012). The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease. Drug Discov Today 17:1160–5
- Uehara S, Uno Y, Inoue T, et al. (2015a). Substrate selectivities and catalytic activities of marmoset liver cytochrome P450 2A6 differed from those of human P450 2A6. Drug Metab Dispos 43:969–76
- Uehara S, Uno Y, Inoue T, et al. (2015b). Novel marmoset cytochrome P450 2C19 in livers efficiently metabolizes human P450 2C9 and 2C19 substrates, S-warfarin, tolbutamide, flurbiprofen, and omeprazole. Drug Metab Dispos 43:1408–16
- Uno Y, Uehara S, Yamazaki H. (2016). Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes. Biochem Pharmacol 121:1–7
- Wang H, Lanza DL, Yost GS. (1998). Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene. Arch Biochem Biophys 349:329–40
- Yamazaki H, Nakamura M, Komatsu T, et al. (2002). Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24:329–37